Avalyn Pharma Inc. (NASDAQ:AVLN) IPO
IPO
Priced at US$18.00 a share on Apr 29, 2026.
- Price
- US$18.00 a share
- Shares offered
- 16,666,667 shares of common stock
- Offering size
- US$300 million
- Underwriters' option
- Up to 2,500,000 more shares
- Listing
- AVLN on the Nasdaq Global Select Market
- Underwriters
- Morgan Stanley, Jefferies, Evercore ISI, Guggenheim Securities · In the order on the cover
- Shares delivered
- On or about May 1, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 6, 2026 |
| Filed publicly | Apr 8, 2026 |
| Amended twice | Newest Apr 29, 2026 |
| Shares registered with an exchange | Apr 27, 2026 |
| Declared effective by the SEC | Apr 29, 2026 |
| Final prospectus, with the price | Apr 30, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Apr 30, 2026 |
| EFFECT · Notice that a registration is effective | Apr 29, 2026 |
| CERT · Exchange's certificate of listing | Apr 29, 2026 |
| S-1/A · Registration statement, amended | Apr 29, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Apr 27, 2026 |
| S-1/A · Registration statement, amended | Apr 23, 2026 |
| S-1 · Registration statement | Apr 8, 2026 |
| DRS/A · Draft registration statement, amended | Mar 18, 2026 |
| DRS · Draft registration statement | Feb 6, 2026 |
From the cover of the final prospectus (424B4) filed Apr 30, 2026